HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stephane Champiat Selected Research

Hepatitis

1/2019Reply to: "Acute liver failure due to immune-mediated hepatitis successfully managed with plasma exchange: New settings call for new treatment strategies?"
10/2018Reply to: "Mortality due to immunotherapy related hepatitis".
1/2018Reply to: "Immune-related hepatitis with immunotherapy: Are corticosteroids always needed?"

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Stephane Champiat Research Topics

Disease

21Neoplasms (Cancer)
05/2024 - 03/2015
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2020 - 03/2015
3Hepatitis
01/2019 - 01/2018
1Esophageal Neoplasms (Esophageal Cancer)
05/2024
1Esophageal Squamous Cell Carcinoma
05/2024
1Myocarditis (Carditis)
01/2023
1Obesity
01/2023
1Pleural Effusion (Pleural Effusions)
01/2023
1Weight Loss (Weight Reduction)
01/2023
1Hepatocellular Carcinoma (Hepatoma)
09/2022
1Exanthema (Rash)
01/2022
1Fatigue
01/2022
1Colorectal Neoplasms (Colorectal Cancer)
01/2020
1HIV Infections (HIV Infection)
01/2020
1Breast Neoplasms (Breast Cancer)
01/2020
1Acute Liver Failure (Fulminant Hepatic Failure)
01/2019
1Melanoma (Melanoma, Malignant)
01/2016
1Infections
01/2012

Drug/Important Bio-Agent (IBA)

9Immune Checkpoint InhibitorsIBA
05/2024 - 03/2015
3Monoclonal AntibodiesIBA
01/2023 - 01/2016
3LigandsIBA
01/2022 - 11/2018
2atezolizumabIBA
05/2024 - 01/2022
2pembrolizumabIBA
01/2023 - 02/2019
2CytokinesIBA
01/2023 - 01/2020
1TroponinIBA
01/2023
1AMG 757IBA
01/2023
1Immunoglobulin G (IgG)IBA
01/2023
1CateninsIBA
01/2023
1DNA (Deoxyribonucleic Acid)IBA
01/2022
1NivolumabIBA
01/2022
1Biomarkers (Surrogate Marker)IBA
01/2022
1Exonucleases (3' 5' Exonuclease)IBA
01/2022
1emactuzumabIBA
01/2022
1Long Noncoding RNAIBA
01/2020
1RNA (Ribonucleic Acid)IBA
01/2020
1Formaldehyde (Formol)FDA Link
01/2020
1ParaffinIBA
01/2020
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2018
1CTLA-4 AntigenIBA
01/2016

Therapy/Procedure

12Immunotherapy
01/2023 - 03/2015
4Therapeutics
05/2024 - 01/2020
4Drug Therapy (Chemotherapy)
09/2022 - 11/2018
1Plasma Exchange
01/2019
1Highly Active Antiretroviral Therapy (HAART)
01/2012